Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Immunic Inc. | 6 | 3 | 0 | 2 | €1.26 | €5.48 | 336.102% |
| EyePoint Pharmaceuticals Inc. | 15 | 1 | 1 | 1 | €9.92 | €27.79 | 180.214% |
| Fate Therapeutics Inc. | 5 | 2 | 2 | 1 | €3.72 | €8.27 | 122.031% |
| Addus Homecare Corp. | 12 | 1 | 1 | 1 | €89.50 | €99.47 | 11.136% |
| X4 Pharmaceuticals, Inc. | 6 | 1 | 3 | 1 | €0.96 | €2.78 | 190.670% |
| Insmed Inc. | 13 | 1 | 2 | 1 | €24.00 | €44.01 | 83.361% |
| Syros Pharmaceuticals Inc. | 5 | 1 | 1 | 1 | €4.62 | €12.80 | 177.089% |
| Valneva SE | 2 | 0 | 0 | 0 | €3.39 | €7.00 | 106.490% |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €7.75 | €8.75 | 12.903% |
| Evolus Inc | 7 | 0 | 2 | 0 | €12.20 | €20.26 | 66.028% |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.22 | €19.86 | 219.628% |
| G1 Therapeutics | 15 | 1 | 3 | 0 | €4.14 | €10.05 | 143.085% |
| Innoviva Inc. | 3 | 0 | 0 | 0 | €14.20 | €30.00 | 111.268% |
| Madrigal Pharmaceuticals inc. | 4 | 0 | 1 | 0 | €207.50 | €315.00 | 51.807% |
| Paul Hartmann AG | 3 | 0 | 0 | 0 | €202.00 | - | - |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.35 | - | - |
| Twist Bioscience Corp | 7 | 0 | 4 | 0 | €40.81 | €41.54 | 1.777% |
| Cocrystal Pharma Inc. | 6 | 0 | 0 | 0 | €1.49 | €10.08 | 576.376% |
| Corvus Pharmaceuticals Inc | 5 | 1 | 1 | 0 | €1.84 | €6.45 | 250.685% |
| Virbac S.A. | 1 | 0 | 0 | 0 | €353.50 | - | - |
| Vericel Corp. | 1 | 0 | 0 | 0 | €43.80 | - | - |
| Vanda Pharmaceuticals | 4 | 0 | 1 | 0 | €4.98 | €5.00 | 0.402% |
| ImmunityBio Inc. | 3 | 0 | 1 | 0 | €7.93 | €10.00 | 26.103% |
| Healthstream Inc. | 4 | 0 | 0 | 0 | €25.00 | €29.29 | 17.171% |